Market Trends of Single-Use Bioprocessing Probes And Sensors Industry
The pH Sensor Segment is Expected to have Major Share in the Market Over the Forecast Period
Single-use pH sensors are factory-calibrated and gamma-sterilizable sensors for integration into single-use processes for the measurement of pH in biopharmaceutical manufacturing. The pH sensor segment is expected to account for a significant share during the forecast period owing to the highest penetration of the product in terms of usage and availability.
The rising technological advancements in single-use pH sensors are further anticipated to increase the demand for these sensors, thereby driving market growth. For instance, according to an article published on single-use pH sensors in Biopharmaceutical Applications in October 2021, advancements in single-use pH sensors have improved quality, reliability, and the level of supplier support. Therefore, the advancements have led pH sensors to provide quality and accuracy for bioprocess single-use applications.
Furthermore, according to a study published in the Pharmaceutical Bioprocessing Journal in January 2023, a pH probe is among the most often used electrochemical sensors for bioprocess monitoring and control. Therefore, the high propensity of usage of pH sensors in the bioreactors is anticipated to drive the market growth over the forecast period.
North America is Expected to Have Largest Share in the Market Over the Forecast Period
The United States represents a significant share of the single-use bioprocessing probes and sensors market due to its well-established biopharmaceutical sector and widespread availability of single-use assemblies supplied by regional market leaders. Furthermore, an increase in investment by the US government to support the bioprocessing industry and a rise in the adoption of bioprocessing probes and sensors are further expected to promote market growth over the forecast period.
The rise in investment in the biopharma field in the United States is further expected to drive market growth over the forecast period. For instance, as per the fact sheet released in September 2022 by the Department of Health and Human Services, the government planned to invest USD 40 million to expand the role of biomanufacturing for active pharmaceutical ingredients (APIs), antibiotics, and the key starting materials needed to produce essential medications. Hence, such investment activities in the United States are likely to positively impact the growth of the single-use bioprocessing probes and sensors market.
Moreover, in November 2022, Cardinal Health expanded its single-use device reprocessing facility in Riverview, Florida, with a capacity of 100,000 square feet. Thus, owing to such strategic expansions by market players, the demand for reprocessing of single-use probes and sensors is likely to rise, thereby fueling the market growth over the forecast period.
